Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 1, Pages 209
Publisher
MDPI AG
Online
2022-01-17
DOI
10.3390/pharmaceutics14010209
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strategies to Design Selective Histone Deacetylase Inhibitors
- (2021) Wolfgang Sippl et al. ChemMedChem
- First‐in‐Class Selective HDAC6 Inhibitor ( ACY ‐1215) Has a Highly Favorable Safety Profile in Patients with Relapsed and Refractory Lymphoma
- (2021) Jennifer E. Amengual et al. ONCOLOGIST
- Natural products in drug discovery: advances and opportunities
- (2021) Atanas G. Atanasov et al. NATURE REVIEWS DRUG DISCOVERY
- HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression
- (2021) Xiaolei Li et al. ONCOGENE
- Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor Interaction
- (2021) Douglas C. Beshore et al. ACS Medicinal Chemistry Letters
- Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
- (2021) Robert Jenke et al. Cancers
- Histone variants at a glance
- (2021) Paul B. Talbert et al. JOURNAL OF CELL SCIENCE
- Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy
- (2021) Qiu-Luo Liu et al. Frontiers in Oncology
- Flavonoids as an effective sensitizer for anti-cancer therapy: insights into multi-faceted mechanisms and applicability towards individualized patient profiles
- (2021) Alena Liskova et al. EPMA Journal
- Romidepsin and lenalidomide‐based regimens have efficacy in relapsed/refractory lymphoma: Combined analysis of two phase I studies with expansion cohorts
- (2021) Neha Mehta‐Shah et al. AMERICAN JOURNAL OF HEMATOLOGY
- A novel histone deacetylase inhibitor MPT0L184 dysregulates cell-cycle checkpoints and initiates unscheduled mitotic signaling
- (2021) Ting-Yu Chang et al. BIOMEDICINE & PHARMACOTHERAPY
- Histone acylations and chromatin dynamics: concepts, challenges, and links to metabolism
- (2021) Sandra Nitsch et al. EMBO REPORTS
- E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group
- (2021) Roisin M. Connolly et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in kinase drug discovery: targets, indications and inhibitor design
- (2021) Misty M. Attwood et al. NATURE REVIEWS DRUG DISCOVERY
- Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration‐Resistant Prostate Cancer
- (2021) Jianqing Lin et al. ONCOLOGIST
- The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
- (2021) Lars Ny et al. Nature Communications
- Strategies for Post-Translational Control of Protein Expression and Their Applications
- (2021) Yuki Utsugi et al. Applied Sciences-Basel
- Deregulation of Transcriptional Enhancers in Cancer
- (2021) Fatemeh Mirzadeh Azad et al. Cancers
- Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
- (2021) Raghuveer Kavarthapu et al. Cancers
- HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
- (2021) Dimitris Karagiannis et al. Cancers
- Selective Histone Deacetylase Inhibitor ACY-241 (Citarinostat) Plus Nivolumab in Advanced Non-Small Cell Lung Cancer: Results From a Phase Ib Study
- (2021) Mark M. Awad et al. Frontiers in Oncology
- Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation
- (2021) Ming He et al. Frontiers in Cell and Developmental Biology
- A structural framework for DNA replication and transcription through chromatin
- (2021) Oliver Willhoft et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Designing HDAC-PROTACs: lessons learned so far
- (2021) Fabian Fischer et al. Future Medicinal Chemistry
- Mechanism of activation and the rewired network: New drug design concepts
- (2021) Ruth Nussinov et al. MEDICINAL RESEARCH REVIEWS
- Phase II study of chidamide in combination with cisplatin in patients with metastatic triple-negative breast cancer
- (2021) Yanchun Meng et al. Annals of Palliative Medicine
- Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
- (2020) George M. Burslem et al. CELL
- A short guide to histone deacetylases including recent progress on class II enzymes
- (2020) Suk-Youl Park et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Role of HDACs in normal and malignant hematopoiesis
- (2020) Pan Wang et al. Molecular Cancer
- Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
- (2020) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Development of Selective Histone Deacetylase 6 (HDAC6) Degraders Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase
- (2020) Ka Yang et al. ACS Medicinal Chemistry Letters
- Role of Histone Deacetylases in Carcinogenesis: Potential Role in Cholangiocarcinoma
- (2020) Kishor Pant et al. Cells
- Genoprotective activities of plant natural substances in cancer and chemopreventive strategies in the context of 3P medicine
- (2020) Lenka Koklesova et al. EPMA Journal
- Discovery of ethyl ketone-based HDACs 1, 2, and 3 selective inhibitors for HIV latency reactivation
- (2020) Wensheng Yu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemical strategies to overcome resistance against targeted anticancer therapeutics
- (2020) Rudolf Pisa et al. Nature Chemical Biology
- Selective Class I HDAC Inhibitors Based on Aryl Ketone Zinc Binding Induce HIV-1 Protein for Clearance
- (2020) Jian Liu et al. ACS Medicinal Chemistry Letters
- Bifunctional HDAC Therapeutics: One Drug to Rule Them All?
- (2020) Joshua P. Smalley et al. MOLECULES
- Synergistic Enhancement of Cancer Therapy Using HDAC Inhibitors: Opportunity for Clinical Trials
- (2020) Lourdes Hontecillas-Prieto et al. Frontiers in Genetics
- The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
- (2020) Guo Li et al. Frontiers in Cell and Developmental Biology
- Safety and Tolerability of Histone Deacetylase (HDAC) Inhibitors in Oncology
- (2019) Rashmi R. Shah DRUG SAFETY
- Developing potent PROTACs tools for selective degradation of HDAC6 protein
- (2019) Zixuan An et al. Protein & Cell
- Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
- (2019) Anna Wawruszak et al. Cancers
- The emerging role of epigenetics in human autoimmune disorders
- (2019) Roberta Mazzone et al. Clinical Epigenetics
- Role of Natural Products in Modulating Histone Deacetylases in Cancer
- (2019) Myriam Merarchi et al. MOLECULES
- The Therapeutic Potential of Apigenin
- (2019) Bahare Salehi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Allyl isothiocyanate regulates lysine acetylation and methylation marks in an experimental model of malignant melanoma
- (2019) Melina Mitsiogianni et al. EUROPEAN JOURNAL OF NUTRITION
- VEGF in Signaling and Disease: Beyond Discovery and Development
- (2019) Rajendra S. Apte et al. CELL
- Anticancer potential of naturally occurring immunoepigenetic modulators: A promising avenue?
- (2019) Michael Schnekenburger et al. CANCER
- A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment
- (2019) Bora Lim et al. BRITISH JOURNAL OF CANCER
- Apoptosis Induction byHistone Deacetylase Inhibitors in Cancer Cells: Role of Ku70
- (2019) Ping Gong et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Natural Compounds against Cancer, Inflammation, and Oxidative Stress
- (2019) Claudio Tabolacci et al. Biomed Research International
- Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy
- (2019) Srimanta Patra et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Comparison of Radiosensitization by HDAC Inhibitors CUDC-101 and SAHA in Pancreatic Cancer Cells
- (2019) Simone Moertl et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Zefei Jiang et al. LANCET ONCOLOGY
- Epigenetic Regulation of p21cip1/waf1 in Human Cancer
- (2019) Matthias Ocker et al. Cancers
- Romidepsin plus Liposomal Doxorubicin is Safe and Effective in Patients with Relapsed or Refractory T-cell Lymphoma: Results of a Phase I Dose-Escalation Study
- (2019) Khoan Vu et al. CLINICAL CANCER RESEARCH
- Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma
- (2019) Anthony Wood et al. INVESTIGATIONAL NEW DRUGS
- Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer
- (2019) Wen‐Jing Liu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells
- (2019) Madhumitha Kedhari Sundaram et al. Genes
- A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer
- (2019) Cristina P. Rodriguez et al. CLINICAL CANCER RESEARCH
- In silico Design of Novel Histone Deacetylase 4 Inhibitors: Design Guidelines for Improved Binding Affinity
- (2019) Shana V. Stoddard et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Molecular Mechanisms of Action of Genistein in Cancer: Recent Advances
- (2019) Hardeep Singh Tuli et al. Frontiers in Pharmacology
- Curcumin and dietary polyphenol research: beyond drug discovery
- (2018) Tian-ru Jin ACTA PHARMACOLOGICA SINICA
- Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells
- (2018) Madhumitha Kedhari Sundaram et al. Anti-Cancer Agents in Medicinal Chemistry
- Plant derived anticancer agents: A green approach towards skin cancers
- (2018) Shakeel Ijaz et al. BIOMEDICINE & PHARMACOTHERAPY
- Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
- (2018) Ka Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Naturally occurring compounds in differentiation based therapy of cancer
- (2018) Sanja Mijatović et al. BIOTECHNOLOGY ADVANCES
- Design of selective histone deacetylase inhibitors: rethinking classical pharmacophore
- (2018) Jelena Melesina et al. Future Medicinal Chemistry
- The HDAC6 inhibitor ACY‑1215 enhances the anticancer activity of oxaliplatin in colorectal cancer cells
- (2018) Dong Hoon Lee et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Zinc binding groups for histone deacetylase inhibitors
- (2018) Lei Zhang et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing
- (2018) Conrad Simoben et al. MOLECULES
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Epigenetics of fragile X syndrome and fragile X-related disorders
- (2018) Claudine M Kraan et al. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY
- Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
- (2018) Ewgenij Proschak et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phenethyl Isothiocyanate Inhibits In Vivo Growth of Xenograft Tumors of Human Glioblastoma Cells
- (2018) Yu-Cheng Chou et al. MOLECULES
- Immune regulation of metastasis: mechanistic insights and therapeutic opportunities
- (2018) Olga S. Blomberg et al. Disease Models & Mechanisms
- Flavonoids in Cancer and Apoptosis
- (2018) Mariam Abotaleb et al. Cancers
- Cancer Chemoprevention: Classic and Epigenetic Mechanisms Inhibiting Tumorigenesis. What Have We Learned So Far?
- (2018) Fabiana Henriques Machado de Melo et al. Frontiers in Oncology
- Design and synthesis of tranylcypromine derivatives as novel LSD1/HDACs dual inhibitors for cancer treatment
- (2017) Ying-Chao Duan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Entinostat for the treatment of breast cancer
- (2017) Dario Trapani et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Entinostat: a promising treatment option for patients with advanced breast cancer
- (2017) Roisin M Connolly et al. Future Oncology
- Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53
- (2017) Maria Mrakovcic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
- (2017) Yuankai Shi et al. Journal of Hematology & Oncology
- Biosynthetic Origin of the Hydroxamic Acid Moiety of Trichostatin A: Identification of Unprecedented Enzymatic Machinery Involved in Hydroxylamine Transfer
- (2017) Kei Kudo et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors
- (2017) Nicholas J. Porter et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors
- (2017) Clare F. Malone et al. Cancer Discovery
- A novel HDAC inhibitor, CG200745, inhibits pancreatic cancer cell growth and overcomes gemcitabine resistance
- (2017) Hee Seung Lee et al. Scientific Reports
- Dietary phytochemical PEITC restricts tumor development via modulation of epigenetic writers and erasers
- (2017) Jung Eun Park et al. Scientific Reports
- Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
- (2016) John A. Halsall et al. BIOESSAYS
- Natural and Synthetic Macrocyclic Inhibitors of the Histone Deacetylase Enzymes
- (2016) Alex R. Maolanon et al. CHEMBIOCHEM
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Inside HDACs with more selective HDAC inhibitors
- (2016) Joëlle Roche et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines
- (2016) Eugene Guorong Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
- (2016) Andrew J Yee et al. LANCET ONCOLOGY
- Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer
- (2016) Hélène Losson et al. MOLECULES
- The multifaceted influence of histone deacetylases on DNA damage signalling and DNA repair
- (2016) Wynand Paul Roos et al. NUCLEIC ACIDS RESEARCH
- The HDACi Panobinostat Shows Growth Inhibition Both In Vitro and in a Bioluminescent Orthotopic Surgical Xenograft Model of Ovarian Cancer
- (2016) Øystein Helland et al. PLoS One
- Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models
- (2016) Pengyu Huang et al. Oncotarget
- HDACs and HDAC Inhibitors in Cancer Development and Therapy
- (2016) Yixuan Li et al. Cold Spring Harbor Perspectives in Medicine
- Histone deacetylase inhibitors in hematological malignancies and solid tumors
- (2015) Pusoon Chun ARCHIVES OF PHARMACAL RESEARCH
- Perspectives in the development of hybrid bifunctional antitumour agents
- (2015) Loana Musso et al. BIOCHEMICAL PHARMACOLOGY
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- Phase I/II study of gefitinib (Iressa®) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
- (2015) Ji-Youn Han et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol
- (2015) Shuyang Chen et al. CELL CYCLE
- CDKN1A histone acetylation and gene expression relationship in gastric adenocarcinomas
- (2015) Fernanda Wisnieski et al. CLINICAL AND EXPERIMENTAL MEDICINE
- An Overview of Naturally Occurring Histone Deacetylase Inhibitors
- (2015) Bumki Kim et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors
- (2015) Eunah Kim et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Histone deacetylases: structural determinants of inhibitor selectivity
- (2015) Carmina Micelli et al. DRUG DISCOVERY TODAY
- Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors
- (2015) Xuan Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
- (2015) Madhusoodanan Mottamal et al. MOLECULES
- Histone Deacetylase Inhibitors Resensitize EGFR/EGFRvIII-Overexpressing, Erlotinib-Resistant Glioblastoma Cells to Tyrosine Kinase Inhibition
- (2015) Katrin Liffers et al. Targeted Oncology
- Diet-Based Strategies for Cancer Chemoprevention: The Role of Combination Regimens Using Dietary Bioactive Components
- (2015) Christina DiMarco-Crook et al. Annual Review of Food Science and Technology
- Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer
- (2015) Lisa Zhang et al. Oncotarget
- Genistein and Cancer: Current Status, Challenges, and Future Directions
- (2015) Carmela Spagnuolo et al. Advances in Nutrition
- HDAC Family Members Intertwined in the Regulation of Autophagy: A Druggable Vulnerability in Aggressive Tumor Entities
- (2015) Emily Koeneke et al. Cells
- Interpreting the language of histone and DNA modifications
- (2014) Scott B. Rothbart et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Plant-derived epigenetic modulators for cancer treatment and prevention
- (2014) Michael Schnekenburger et al. BIOTECHNOLOGY ADVANCES
- Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
- (2014) M. Bots et al. BLOOD
- A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma
- (2014) Francine Foss et al. BRITISH JOURNAL OF HAEMATOLOGY
- Histone deacetylase inhibitors and cell death
- (2014) Jing Zhang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Curcumin Augments the Efficacy of Antitumor Drugs Used in Leukemia by Modulation of Heat Shock Proteins Via HDAC6
- (2014) Ruma Sarkar et al. JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Exploiting epigenetic vulnerabilities for cancer therapeutics
- (2014) Barbara Mair et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
- (2014) Shalome Bassett et al. Nutrients
- Sulforaphane enhances Nrf2 expression in prostate cancer TRAMP C1 cells through epigenetic regulation
- (2013) Chengyue Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Protein quality control and elimination of protein waste: The role of the ubiquitin–proteasome system
- (2013) Ingo Amm et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cancer chemoprevention: a rapidly evolving field
- (2013) W P Steward et al. BRITISH JOURNAL OF CANCER
- The Effect of Various Zinc Binding Groups on Inhibition of Histone Deacetylases 1-11
- (2013) Andreas S. Madsen et al. ChemMedChem
- Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy
- (2013) Elena Lecumberri et al. CLINICAL NUTRITION
- Polyamines and cancer: implications for chemotherapy and chemoprevention
- (2013) Shannon L. Nowotarski et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Inhibition of HDAC6 Deacetylase Activity Increases Its Binding with Microtubules and Suppresses Microtubule Dynamic Instability in MCF-7 Cells
- (2013) Jayant Asthana et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability
- (2013) Benjamin E. L. Lauffer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Randomized Phase II, Double-Blind, Placebo-Controlled Study of Exemestane With or Without Entinostat in Postmenopausal Women With Locally Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer Progressing on Treatment With a Nonsteroidal Aromatase Inhibitor
- (2013) Denise A. Yardley et al. JOURNAL OF CLINICAL ONCOLOGY
- Potent and Selective Inhibition of Histone Deacetylase 6 (HDAC6) Does Not Require a Surface-Binding Motif
- (2013) Florence F. Wagner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
- (2013) Yuanyuan Li et al. Molecular Cancer
- Curcumin as a regulator of epigenetic events
- (2013) Marie-Hélène Teiten et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group
- (2013) Mercedes Lobera et al. Nature Chemical Biology
- Small Molecule Inhibitors of Zinc-dependent Histone Deacetylases
- (2013) Florence F. Wagner et al. Neurotherapeutics
- Phenethyl Isothiocyanate Inhibits Proliferation and Induces Apoptosis in Pancreatic Cancer CellsIn Vitroand in a MIAPaca2 Xenograft Animal Model
- (2013) Silvia D. Stan et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Epigenetic Regulation of Multiple Tumor-Related Genes Leads to Suppression of Breast Tumorigenesis by Dietary Genistein
- (2013) Yuanyuan Li et al. PLoS One
- Correction: Resveratrol as a Pan-HDAC Inhibitor Alters the Acetylation Status of Jistone Proteins in Human-Derived Hepatoblastoma Cells
- (2013) Sascha Venturelli et al. PLoS One
- A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways
- (2013) Fei-Fei Gan et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells
- (2013) A Scuto et al. Cell Death & Disease
- Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma
- (2012) L. Santo et al. BLOOD
- Plant HDAC inhibitor chrysin arrest cell growth and induce p21 WAF1 by altering chromatin of STAT response element in A375 cells
- (2012) Manika Pal-Bhadra et al. BMC CANCER
- Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells
- (2012) Cornel J Phillip et al. BMC CANCER
- Selenium-containing histone deacetylase inhibitors for melanoma management
- (2012) Raghavendra Gowda et al. CANCER BIOLOGY & THERAPY
- Cancer Genetics and Epigenetics: Two Sides of the Same Coin?
- (2012) Jueng Soo You et al. CANCER CELL
- The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer
- (2012) Kim Tran et al. CARCINOGENESIS
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
- (2012) Farhat V.N. Din et al. GASTROENTEROLOGY
- Histone deacetylase modulators provided by Mother Nature
- (2012) Carole Seidel et al. Genes and Nutrition
- SAHA Inhibits the Growth of Colon Tumors by Decreasing Histone Deacetylase and the Expression of Cyclin D1 and Survivin
- (2012) Jong-Shiaw Jin et al. PATHOLOGY & ONCOLOGY RESEARCH
- Epigenetic impact of dietary polyphenols in cancer chemoprevention: Lifelong remodeling of our epigenomes
- (2012) Wim Vanden Berghe PHARMACOLOGICAL RESEARCH
- Trichostatin A Abrogates Airway Constriction, but Not Inflammation, in Murine and Human Asthma Models
- (2011) Audreesh Banerjee et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications
- (2011) Brahma N. Singh et al. BIOCHEMICAL PHARMACOLOGY
- Curcumin-induced HDAC inhibition and attenuation of medulloblastoma growth in vitro and in vivo
- (2011) Seung Joon Lee et al. BMC CANCER
- Chidamide (CS055/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity
- (2011) Zhi-Qiang Ning et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells
- (2011) V. Nandakumar et al. CARCINOGENESIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Epigenetic modifications in cancer
- (2011) R Kanwal et al. CLINICAL GENETICS
- Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
- (2011) Patrick M Lombardi et al. CURRENT OPINION IN STRUCTURAL BIOLOGY
- Mocetinostat (MGCD0103): a review of an isotype-specific histone deacetylase inhibitor
- (2011) Yanis Boumber et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Rational therapeutic combinations with histone deacetylase inhibitors for the treatment of cancer
- (2011) K Ted Thurn et al. Future Oncology
- Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer
- (2011) Ali Aghdassi et al. GUT
- Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
- (2011) Karen M VanderMolen et al. JOURNAL OF ANTIBIOTICS
- HDAC4 Protein Regulates HIF1α Protein Lysine Acetylation and Cancer Cell Response to Hypoxia
- (2011) Hao Geng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autophagic and Apoptotic Effects of HDAC Inhibitors on Cancer Cells
- (2011) Hidemi Rikiishi JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: In vitro and in vivo study
- (2011) Mitali Pandey et al. MOLECULAR CARCINOGENESIS
- The Flavonoid Quercetin Modulates the Hallmark Capabilities of Hamster Buccal Pouch Tumors
- (2011) Ramamurthi Vidya Priyadarsini et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Natural Products as Chemical Probes
- (2010) Erin E. Carlson ACS Chemical Biology
- Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma
- (2010) Yuan-Ling Liu et al. Autophagy
- CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity
- (2010) Cheng-Jung Lai et al. CANCER RESEARCH
- Chemopreventive Agent 3,3'-Diindolylmethane Selectively Induces Proteasomal Degradation of Class I Histone Deacetylases
- (2010) Y. Li et al. CANCER RESEARCH
- Anticancer Properties of Indole Compounds: Mechanism of Apoptosis Induction and Role in Chemotherapy
- (2010) Aamir Ahmad et al. CURRENT DRUG TARGETS
- Macrocyclic Histone Deacetylase Inhibitors
- (2010) Sandra C. Mwakwari et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Curcumin p38-dependently enhances the anticancer activity of valproic acid in human leukemia cells
- (2010) Jie Chen et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Expression of H3K9Ac, H3K14Ac, and H4K20TriMe in Epithelial Ovarian Tumors and the Clinical Significance
- (2010) Li Zhen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Synergistic epigenetic reactivation of estrogen receptor-alpha (ERalpha) by combined green tea polyphenol and histone deacetylase inhibitor in ERalpha-negative breast cancer cells
- (2010) Yuanyuan Li et al. Molecular Cancer
- Benzyl Isothiocyanate-Mediated Inhibition of Histone Deacetylase Leads to NF- B Turnoff in Human Pancreatic Carcinoma Cells
- (2010) S. Batra et al. MOLECULAR CANCER THERAPEUTICS
- Short-Chain HDAC Inhibitors Differentially Affect Vertebrate Development and Neuronal Chromatin
- (2010) Daniel M. Fass et al. ACS Medicinal Chemistry Letters
- Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
- (2010) Julia M. Wagner et al. Clinical Epigenetics
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- 3,3'-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention through Down-Regulation of Survivin
- (2009) N. Bhatnagar et al. Cancer Prevention Research
- Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors
- (2009) H Miles Prince et al. Future Oncology
- E-Cadherin Regulates Metastasis of Pancreatic Cancer In Vivo and Is Suppressed by a SNAIL/HDAC1/HDAC2 Repressor Complex
- (2009) Johannes von Burstin et al. GASTROENTEROLOGY
- Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells
- (2009) Mitali Pandey et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre
- (2009) Daniel Scharlau et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Multiple roles of HDAC inhibition in neurodegenerative conditions
- (2009) De-Maw Chuang et al. TRENDS IN NEUROSCIENCES
- Cancer Prevention: Epigenetics Steps Up to the Plate
- (2008) J.-P. Issa Cancer Prevention Research
- Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter
- (2008) H. Nian et al. CARCINOGENESIS
- Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor
- (2008) Christophe Le Tourneau et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Induction of autophagy in malignant rhabdoid tumor cells by the histone deacetylase inhibitor FK228 through AIF translocation
- (2008) Motonobu Watanabe et al. INTERNATIONAL JOURNAL OF CANCER
- Polyaminohydroxamic Acids and Polyaminobenzamides as Isoform Selective Histone Deacetylase Inhibitors§
- (2008) Sheeba Varghese et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started